Cargando…

Association of Sweet's Syndrome and Systemic Lupus Erythematosus

Sweet's syndrome is an acute febrile neutrophilic dermatosis which usually presents as an idiopathic disorder but can also be drug induced, associated with hematopoetic malignancies and myelodysplastic disorders, and more, infrequently, observed in autoimmune disorders. Sweet's syndrome ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barton, J. L., Pincus, L., Yazdany, J., Richman, N., McCalmont, T. H., Gensler, L., Dall'Era, M., Fye, K. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420725/ https://www.ncbi.nlm.nih.gov/pubmed/22937442 http://dx.doi.org/10.1155/2011/242681

Ejemplares similares

Differential regulation of the interferon response in systemic lupus erythematosus distinguishes patients of Asian ancestry
por: Rector, Ian, et al.
Publicado: (2023)

Patient-Centered Outcomes Research Institute (PCORI) multisite project to develop treatment decision aids for racial/ethnic minorities with lupus nephritis
por: Yazdany, Jinoos, et al.
Publicado: (2014)

Estimates of Responsiveness, Minimally Important Differences, and Patient Acceptable Symptom State in Five Patient‐Reported Outcomes Measurement Information System Short Forms in Systemic Lupus Erythematosus
por: Katz, Patricia, et al.
Publicado: (2019)

Mortality Among Minority Populations with Systemic Lupus Erythematosus, Including Asian and Hispanic/Latino Persons — California, 2007–2017
por: Gianfrancesco, Milena A., et al.
Publicado: (2021)

A glimpse into the future of systemic lupus erythematosus
por: Aringer, Martin, et al.
Publicado: (2022)

Preliminary population-based incidence and prevalence estimates of systemic lupus erythematosus: the California Lupus Surveillance Project
por: Dall'Era, Maria C, et al.
Publicado: (2014)

Neonatal lupus erythematosus or Sweet syndrome?
por: Spengane, Zandile, et al.
Publicado: (2018)

Dynamics of Methylation of CpG Sites Associated With Systemic Lupus Erythematosus Subtypes in a Longitudinal Cohort
por: Lanata, Cristina M., et al.
Publicado: (2022)

Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USA
por: Collins, C E, et al.
Publicado: (2016)

A phenotypic and genomics approach in a multi-ethnic cohort to subtype systemic lupus erythematosus
por: Lanata, Cristina M., et al.
Publicado: (2019)

Author Correction: A phenotypic and genomics approach in a multi-ethnic cohort to subtype systemic lupus erythematosus
por: Lanata, Cristina M., et al.
Publicado: (2020)

Molecular pathways identified from single nucleotide polymorphisms demonstrate mechanistic differences in systemic lupus erythematosus patients of Asian and European ancestry
por: Owen, Katherine A., et al.
Publicado: (2023)

Transcriptomic analysis of immune cells in a multi-ethnic cohort of systemic lupus erythematosus patients identifies ethnicity- and disease-specific expression signatures
por: Andreoletti, Gaia, et al.
Publicado: (2021)

Incidence rates of systemic lupus erythematosus in the USA: estimates from a meta-analysis of the Centers for Disease Control and Prevention national lupus registries
por: Izmirly, Peter M, et al.
Publicado: (2021)

Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus
por: Urowitz, Murray B., et al.
Publicado: (2022)

Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment
por: Kirou, Kyriakos A., et al.
Publicado: (2022)

Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria
por: van Vollenhoven, Ronald, et al.
Publicado: (2022)

Identification of clinical and serological factors during induction treatment of lupus nephritis that are associated with renal outcome
por: Dall'Era, Maria, et al.
Publicado: (2015)

Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibitor Evobrutinib in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double‐Blind, Placebo‐Controlled Dose‐Ranging Trial
por: Wallace, Daniel J., et al.
Publicado: (2022)

Approaches for estimating minimal clinically important differences in systemic lupus erythematosus
por: Rai, Sharan K, et al.
Publicado: (2015)

Outcome of participants with nephrotic syndrome in combined clinical trials of lupus nephritis
por: Gomez Mendez, Liliana Michelle, et al.
Publicado: (2019)

Postoperative Major Adverse Cardiac Events in Patients With Systemic Lupus Erythematosus
por: Bruera, Sebastian, et al.
Publicado: (2022)

Are patient ratings of interactions with providers and health plans associated with technical quality of care in systemic lupus erythematosus?
por: Yelin, Edward, et al.
Publicado: (2014)

Indications for and transitioning to secondary treatment while on active surveillance for prostate cancer
por: Glass, Allison S., et al.
Publicado: (2018)

Active Surveillance for Intermediate Risk Prostate Cancer
por: Dall'Era, Marc A., et al.
Publicado: (2016)

Defining the Optimal Management Strategy for Small Renal Masses
por: Dall’Era, Marc, et al.
Publicado: (2021)

Systemic Lupus Erythematosus Management in Pregnancy
por: Dao, Kathryn H, et al.
Publicado: (2022)

Treatment of systemic lupus erythematosus
por: McKeon, Kathryn P, et al.
Publicado: (2020)

Systemic lupus erythematosus with nephropathy.
por: Hayslett, J. P., et al.
Publicado: (1995)

Active Surveillance for Localized Prostate Cancer – Current Practices and Recommendations
por: Wu, Jennifer N., et al.
Publicado: (2010)

Creatinine Fluctuation in Patients With Lupus Nephritis: Considerations for Clinical Trial Endpoints
por: Almaani, Salem, et al.
Publicado: (2020)

Active surveillance for prostate cancer
por: Dall’Era, Marc A., et al.
Publicado: (2018)

Adipocyte-Like Differentiation in a Posttreatment Embryonal Rhabdomyosarcoma
por: Balitzer, Dana, et al.
Publicado: (2015)

Systemic lupus erythematosus.
por: Richardson, J.
Publicado: (1969)

Non-Full House Membranous Lupus Nephritis Represents a Clinically Distinct Subset
por: Ye, Julia, et al.
Publicado: (2023)

An Operational In Situ Soil Moisture & Soil Temperature Monitoring Network for West Wales, UK: The WSMN Network
por: Petropoulos, George P., et al.
Publicado: (2017)

Systemic lupus erythematosus
por: Manson, Jessica J, et al.
Publicado: (2006)

Systemic lupus erythematosus-myositis overlap syndrome with lupus nephritis
por: Dey, Biswajit, et al.
Publicado: (2020)

Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
por: Plüß, Marlene, et al.
Publicado: (2022)

Neuropsychiatric Systemic Lupus Erythematosus
por: Popescu, Alexandra, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2h79och3lea3c929f2fgfsb4hd